Recalls / Brands / Irbesartan And Hydrochlorothiazide
Irbesartan And Hydrochlorothiazide
6 FDA drug recalls involving brand “Irbesartan And Hydrochlorothiazide”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2019-01-18 | Class II | Irbesartan and Hydrochlorothiazide Tablets, USP 150/12.5 mg Rx 30 Tablets Only Manufactured by: Zhejiang Huaha | Prinston Pharmaceutical Inc |
| 2019-01-18 | Class II | Irbesartan and HydrochlorothiazideTablets, USP 150/12.5 mg Rx Only 90 count Manufactured by: Zhejiang Huah | Prinston Pharmaceutical Inc |
| 2019-01-18 | Class II | Irbesartan and Hydrochlorothiazide Tablets, USP 300/12.5 mg Rx Only Manufactured by: Zhejiang Huahai Pharmaceu | Prinston Pharmaceutical Inc |
| 2019-01-18 | Class II | Irbesartan and Hydrochlorothiazide Tablets, USP 300/12.5 mg Rx Only Manufactured by: Zhejiang Huahai Pharmaceu | Prinston Pharmaceutical Inc |
| 2016-05-30 | Class III | Irbesartan and Hydrochlorothiazide Tablets, USP, 300/12.5 mg, Rx only, Manufactured by: Zhejiang Huahai Pharma | Prinston Pharmaceutical Inc |
| 2015-10-20 | Class III | Irbesartan and Hydrochlorothiazide tablets USP 150 mg/ 12.5 mg, 90-count bottles, Rx only, Manufactured in Isr | Teva Pharmaceutical Industries |